Loading...

Willow Biosciences Inc.

WLLW.TOTSX
Healthcare
Drug Manufacturers - Specialty & Generic
$0.04
$0.00(0.00%)
Canadian Market opens in NaNh NaNm

Willow Biosciences Inc. (WLLW.TO) Stock Competitors & Peer Comparison

See (WLLW.TO) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
WLLW.TOCA$0.04+0.00%5.2M-0.22-CA$0.16N/A
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
CURA.TOCA$4.24+13.37%3.2B-9.45-CA$0.44N/A
BHC.TOCA$8.01-1.05%3B13.93CA$0.58N/A
GTII.CNCA$9.89+6.92%2.3B15.15CA$0.66N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
TRUL.CNCA$9.60+10.09%1.6B-11.97-CA$0.80N/A
CRON.TOCA$3.73+0.81%1.4B-126.00-CA$0.03N/A
TLRY.TOCA$9.60+1.59%1.1B-0.49-CA$20.09N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

WLLW.TO vs CURA.CN Comparison April 2026

WLLW.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WLLW.TO stands at 5.2M. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, WLLW.TO is priced at CA$0.04, while CURA.CN trades at CA$5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WLLW.TO currently has a P/E ratio of -0.22, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, WLLW.TO's ROE is -0.09%, compared to CURA.CN's ROE of -0.24%. Regarding short-term risk, WLLW.TO is more volatile compared to CURA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for WLLW.TO.Check CURA.CN's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions